Gland Pharma schedules investor meeting with WhiteOak Capital

Gland Pharma Limited will hold a one-on-one meeting with WhiteOak Capital on September 22, 2025. This interaction is being conducted in accordance with Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company noted that the schedule of these meetings is subject to change, with potential alterations occurring due to exigencies on the part of the investor, analyst, or the company itself.

This announcement was formally communicated by Sampath Kumar Pallerlamudi, company secretary & compliance officer, on September 17, 2025, to both BSE Limited and the National Stock Exchange of India Limited. The intimation ensures transparency regarding Gland Pharma's ongoing engagement with the investment community.